Appropriateness of aminoglycoside prescriptions in a French university hospital

Affiliation auteurs!!!! Error affiliation !!!!
TitreAppropriateness of aminoglycoside prescriptions in a French university hospital
Type de publicationJournal Article
Year of Publication2016
AuteursMuller A., Leroy J., Patry I., Henon T., Hocquet D., Chirouze C., Bertrand X.
JournalMEDECINE ET MALADIES INFECTIEUSES
Volume46
Pagination308-313
Date PublishedSEP
Type of ArticleArticle
ISSN0399-077X
Mots-clésaminoglycosides, Antibiotic stewardship
Résumé

Introduction. - Aminoglycosides are a major class of antibiotics. Their use is particularly interesting in the treatment of severe infections but their toxicity is well known. They are mostly prescribed combined with other agents and as first-line treatments. We aimed to assess the appropriateness of aminoglycoside prescriptions in a French university hospital on the basis of the latest French recommendations published in 2011. Method. - We conducted a prospective study between January 17th and February 4th, 2014 to assess prescription modalities of aminoglycosides on the basis of the following criteria: indication, duration of treatment, dosing schedule, administration modalities, and drug level monitoring. Prescriptions were then compared to the 2011 national guidelines. Results. - A total of 68 consecutive prescriptions were analyzed and only 47.8% complied with guidelines. Most physicians complied with recommendations, particularly with the indication for severe infections (95.6%), the administration of a single daily dose (92.6%), and the slow intravenous infusion (30 minutes) administration (84%). However, physicians tended to prescribe lower doses than recommended (40.3%), especially to patients presenting with renal insufficiency, and drug level monitoring was not optimal. Conclusion. - Although new and accurate national recommendations were recently published, aminoglycoside prescription is still not optimal, in particular for dosing and plasma concentration monitoring. (C) 2016 Elsevier Masson SAS. All rights reserved.

DOI10.1016/j.medmal.2016.04.009